Apomorphine for prolonged disorders of consciousness: a multimodal open-label studyResearch in context

Summary: Background: Apomorphine is a dopaminergic candidate therapy to improve recovery in patients with prolonged disorders of consciousness (PDoC). Behavioural improvements were previously described in non-controlled case series, but its efficacy and neural mechanisms remain largely unknown. Thi...

Full description

Bibliographic Details

Published in:	EClinicalMedicine
Main Authors:	Leandro R.D. Sanz, Nicolas Lejeune, Emilie Szymkowicz, Estelle A.C. Bonin, Rajanikant Panda, Arianna Sala, Aurore Thibaut, Rodrigo Huerta-Gutierrez, Nadia Dardenne, David Dikenstein, Sébastien Van Goethem, Didier Ledoux, Roland Hustinx, Johan Stender, Neal M. Farber, Ross D. Zafonte, Nicholas D. Schiff, Steven Laureys, Olivia Gosseries
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Disorders of consciousness Coma Severe brain injury Unresponsive wakefulness syndrome Vegetative state Minimally conscious state
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537024005042